Mouse S100B(S100 Calcium Binding Protein B) ELISA Kit
中文名称:小鼠S100钙结合蛋白B(S100B)酶联免疫吸附测定试剂盒

Price:
- 反应性: Mouse
- 检测范围: 78.13-5000 pg/mL
- 灵敏度: 46.88 pg/mL
产品应用 | ELISA |
检测原理 | 本试剂盒采用双抗体夹心ELISA法。用抗小鼠S100B抗体包被于酶标板上,实验时样品(或标准品)中的小鼠S100B会与包被抗体结合。后依次加入生物素化的抗小鼠S100B抗体和辣根过氧化物酶标记的亲和素,抗小鼠S100B抗体与结合在包被抗体上的小鼠S100B结合,生物素与亲和素特异性结合而形成免疫复合物,游离的成分被洗去。加入显色底物(TMB),TMB在辣根过氧化物酶的催化下呈现蓝色,加终止液后变成黄色。用酶标仪在450 nm波长处测OD值,S100B浓度与OD450值之间呈正比,通过绘制标准曲线计算出样品中S100B的浓度。 |
反应类型 | Sandwich-ELISA |
规格 |
96 T
/ 48 T
/ 96 T × 5
|
反应时间 | 3 h 30 min |
反应性 | Mouse |
检测方法 | 比色法;ELISA;夹心法 |
检测范围 | 78.13-5000 pg/mL |
灵敏度 | 46.88 pg/mL |
样本体积 | 100 μL |
样本类型 | 血清、血浆或其他生物体液 |
特异性 | 可检测样本中的小鼠S100B,且与其它类似物无明显交叉反应 |
精密度 | 板内,板间变异系数均<10% |
回收率 | 80%-120% |
储存条件 | 2-8℃ |
有效期 | 12个月 |
数据处理 |
-
ML218 modulates calcium binding protein, oxidative stress, and inflammation during ischemia-reperfusion brain injury in mice
IF: 4.200Journal: EUROPEAN JOURNAL OF PHARMACOLOGY (2024)Reactivity:MouseSample Type:Serum -
Malvidin alleviates mitochondrial dysfunction and ROS accumulation through activating AMPK-α/UCP2 axis, thereby resisting inflammation and apoptosis in SAE mice
IF: 5.600 -
Prior nasal delivery of antagomiR-122 prevents radiation-induced brain injury
IF: 11.454 -
The receptor for advanced glycation end products mediates dysfunction of airway epithelial barrier in a lipopolysaccharides-induced murine acute lung injury model
IF: 4.932Journal: INTERNATIONAL IMMUNOPHARMACOLOGY (2021)PMID:33548580Reactivity:MouseSample Type:Bronchoalveolar Lavage Fluid -
Hippocampal microglia CD40 mediates NPSLE cognitive dysfunction in mice
IF: 3.478 -
Key role of Extracellular RNA in hypoxic stress induced myocardial injury
IF: 3.240 -
Kinin B2 Receptor Activation Prevents the Evolution of Alzheimer’s Disease Pathological Characteristics in a Transgenic Mouse Model
IF: 4.286 -
Neuroprotective Effects of Kinin B2 Receptor in Organotypic Hippocampal Cultures of Middle-Aged Mice
IF: 3.633Journal: Frontiers in Aging Neuroscience (2019)PMID:31354470Reactivity:MouseSample Type:hippocampal -
Inducing a Transient Increase in Blood–Brain Barrier Permeability for Improved Liposomal Drug Therapy of Glioblastoma Multiforme
IF: 13.709